Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pessayre

Showing results (31-40 of 198) with videos related to

Pageof 20
Sort By:
Gastroenterologie Clinique Et Biologique|October 8, 1998
[Role of mitochondria in drug-induced hepatotoxicity]A Berson, B Fromenty, P Lettéron, et al.
Seminars in Liver Disease|April 12, 2001
Mitochondria in steatohepatitisD Pessayre, A Berson, B Fromenty, et al.
Clinical Science (London, England : 1979)|August 1, 1983
Propranolol does not further decrease the clearance of antipyrine in patients with alcoholic cirrhosisD Larrey, D Lebrec, E Bercoff, et al.
Cell Biology and Toxicology|May 16, 2000
Hepatotoxicity due to mitochondrial dysfunctionD Pessayre, A Mansouri, D Haouzi, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1982
Self-induction by oleandomycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Comparison with troleandomycinD Pessayre, V Descatoire, M Tinel, et al.
Nucleic Acids Research|June 28, 2000
Escherichia coli exonuclease III enhances long PCR amplification of damaged DNA templatesB Fromenty, C Demeilliers, A Mansouri, et al.
Journal of Hepatology|December 1, 1994
Possible association between poor metabolism of mephenytoin and hepatotoxicity caused by Atrium, a fixed combination preparation containing phenobarbital, febarbamate and difebarbamateY Horsmans, D Lannes, D Pessayre, et al.
Gastroenterologie Clinique Et Biologique|April 1, 1983
[Hepatitis caused by various derivatives of erythromycin]C Funck-Brentano, D Pessayre, J P Benhamou
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Hepatotoxicity of antimicrobial agents. I: Antibacterial antibiotics]Y Horsmans, D Larrey, D Pessayre, et al.
Digestive Diseases and Sciences|September 1, 1994
Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatinS Grimbert, D Pessayre, C Degott, et al.
Pageof 20

Showing results (31-40 of 198) with videos related to

Sort By:
Pageof 20
Gastroenterologie Clinique Et Biologique|October 8, 1998
[Role of mitochondria in drug-induced hepatotoxicity]A Berson, B Fromenty, P Lettéron, et al.
Seminars in Liver Disease|April 12, 2001
Mitochondria in steatohepatitisD Pessayre, A Berson, B Fromenty, et al.
Clinical Science (London, England : 1979)|August 1, 1983
Propranolol does not further decrease the clearance of antipyrine in patients with alcoholic cirrhosisD Larrey, D Lebrec, E Bercoff, et al.
Cell Biology and Toxicology|May 16, 2000
Hepatotoxicity due to mitochondrial dysfunctionD Pessayre, A Mansouri, D Haouzi, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1982
Self-induction by oleandomycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Comparison with troleandomycinD Pessayre, V Descatoire, M Tinel, et al.
Nucleic Acids Research|June 28, 2000
Escherichia coli exonuclease III enhances long PCR amplification of damaged DNA templatesB Fromenty, C Demeilliers, A Mansouri, et al.
Journal of Hepatology|December 1, 1994
Possible association between poor metabolism of mephenytoin and hepatotoxicity caused by Atrium, a fixed combination preparation containing phenobarbital, febarbamate and difebarbamateY Horsmans, D Lannes, D Pessayre, et al.
Gastroenterologie Clinique Et Biologique|April 1, 1983
[Hepatitis caused by various derivatives of erythromycin]C Funck-Brentano, D Pessayre, J P Benhamou
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Hepatotoxicity of antimicrobial agents. I: Antibacterial antibiotics]Y Horsmans, D Larrey, D Pessayre, et al.
Digestive Diseases and Sciences|September 1, 1994
Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatinS Grimbert, D Pessayre, C Degott, et al.
Pageof 20